Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,

Slides:



Advertisements
Similar presentations
Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl) Pre dialysis SBP (mmHg) Pre dialysis DBP(mmHg) Post dialysis SBP (mmHg)
Advertisements

Ischemic heart disease after renal transplantation
Copyright © 2014 American Medical Association. All rights reserved.
Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
Association of blood lipids with AF
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Association of low eosinophil and lymphocyte counts with different initial presentations of cardiovascular disease over the first 6 months ‘Low eosinophils’
Anemia management in chronic kidney disease
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure  Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.
Volume 79, Issue 9, Pages (May 2011)
Volume 58, Issue 1, Pages (July 2000)
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
Volume 93, Issue 4, Pages (April 2018)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Rajiv Agarwal, John W. Kusek, Maria K. Pappas  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes  Robert W. Schrier, Raymond.
Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan 
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Associations of Coffee, Tea, and Caffeine Intake with Coronary Artery Calcification and Cardiovascular Events  P. Elliott Miller, MD, Di Zhao, PhD, Alexis.
Volume 86, Issue 4, Pages (October 2014)
Volume 64, Issue 2, Pages (August 2003)
Volume 79, Pages S9-S13 (April 2011)
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.
Volume 81, Issue 3, Pages (February 2012)
Volume 79, Issue 12, Pages (June 2011)
Volume 93, Issue 1, Pages (January 2018)
Vitality Measured as Self-reported Energy Level and Clinical Outcomes in Hemodialysis Patients: The Japanese Dialysis Outcomes and Practice Pattern Study.
How to interpret the eGFR in patients with small body surface area
Volume 77, Issue 7, Pages (April 2010)
Dyslipidemia in children with chronic kidney disease
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 74, Issue 9, Pages (November 2008)
Volume 86, Issue 3, Pages (September 2014)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Volume 58, Issue 1, Pages (July 2000)
Volume 67, Issue 1, Pages (January 2005)
Volume 82, Issue 7, Pages (October 2012)
Volume 87, Issue 1, Pages (January 2015)
Volume 73, Issue 8, Pages (April 2008)
Volume 58, Issue 3, Pages (September 2000)
Volume 58, Issue 1, Pages (July 2000)
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome  Lucas Bandeira Marchesan, B.Sc., Poli Mara Spritzer,
Lars E. Laugsand et al. BTS 2016;j.jacbts
The course of the remnant kidney model in mice
Volume 80, Issue 10, Pages (November 2011)
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Is it the low-protein diet or simply the salt restriction?
Pathophysiology of cardiovascular disease in hemodialysis patients
Volume 75, Issue 1, Pages (January 2009)
Volume 59, Issue 5, Pages (May 2001)
Is There an “Asymptote of Gain” Beyond Which Further Increases in Cardiorespiratory Fitness Convey No Additional Benefits on Mortality and Atrial Fibrillation? 
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Ischemic heart disease after renal transplantation
Volume 81, Issue 11, Pages (June 2012)
Volume 61, Issue 1, Pages (January 2002)
Friends, social networks, and progressive chronic kidney disease
J. David Spence, BA, MBA, MD  Canadian Journal of Cardiology 
HR for mortality in ischemic heart disease.
Presentation transcript:

Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick, Michel Chonchol, Hannes Gnahn, Dirk Sander  Kidney International  Volume 77, Issue 9, Pages 794-800 (May 2010) DOI: 10.1038/ki.2009.557 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Carotid intima–media thickness according to systolic blood pressure and kidney function at initiation of the study. The covariate-adjusted means (95% CI) for carotid intima–media thickness (mm) at baseline are shown. P by ANCOVA for Ccr ≥60 ml/min=0.02; Ccr<60 ml/min=0.01. Adjusted for age, sex, body mass index, smoking, prevalent ischemic heart disease, stroke, baseline diastolic blood pressure, antihypertensive medications, statin administration, aspirin usage, low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, triglycerides, glycosylated hemoglobin, C-reactive protein, and homocysteine. ANCOVA, analysis of covariance; Ccr, creatinine clearance; CI, confidence interval; IMT, intima–media thickness. Kidney International 2010 77, 794-800DOI: (10.1038/ki.2009.557) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Carotid intima–media thickness according to pulse pressure and kidney function at initiation of the study. The covariate-adjusted means (95% CI) for carotid intima–media thickness (mm) at baseline are shown. P by ANCOVA for Ccr≥60 ml/min=0.01; Ccr<60 ml/min=0.01. Adjusted for age, sex, body mass index, smoking, prevalent ischemic heart disease, stroke, baseline systolic and diastolic blood pressures, antihypertensive medications, statin administration, aspirin usage, low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, triglycerides, glycosylated hemoglobin, C-reactive protein, and homocysteine. ANCOVA, analysis of covariance; Ccr, creatinine clearance; CI, confidence interval; IMT, intima–media thickness. Kidney International 2010 77, 794-800DOI: (10.1038/ki.2009.557) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Carotid intima–media thickness progression according to systolic blood pressure and kidney function at baseline. The covariate-adjusted means (95% CI) for carotid intima–media thickness progression (mm per year) are shown. P by ANCOVA for Ccr≥60 ml/min=0.007; Ccr<60 ml/min=0.01. Adjusted for age, sex, body mass index, smoking, prevalent ischemic heart disease, stroke, baseline diastolic blood pressure, antihypertensive medications, statin administration, aspirin usage, low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, triglycerides, glycosylated hemoglobin, C-reactive protein, homocysteine, and baseline carotid intima media–thickness. ANCOVA, analysis of covariance; Ccr, creatinine clearance; CI, confidence interval; IMT, intima–media thickness. Kidney International 2010 77, 794-800DOI: (10.1038/ki.2009.557) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Carotid intima–media thickness progression according to pulse pressure and kidney function at baseline. The covariate-adjusted means (95% CI) for carotid intima–media thickness (mm per year) are shown. P by ANCOVA for Ccr≥60 ml/min=0.011; Ccr<60 ml/min=0.009. Adjusted for age, sex, body mass index, smoking, prevalent ischemic heart disease, stroke, baseline systolic and diastolic blood pressures, antihypertensive medications, statin administration, aspirin usage, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, triglycerides, glycosylated hemoglobin, C-reactive protein, homocysteine, and baseline carotid intima–media thickness. ANCOVA, analysis of covariance; Ccr, creatinine clearance; CI, confidence interval; IMT, intima–media thickness. Kidney International 2010 77, 794-800DOI: (10.1038/ki.2009.557) Copyright © 2010 International Society of Nephrology Terms and Conditions